Growth Metrics

Innoviva (INVA) EPS (Weighted Average and Diluted) (2016 - 2025)

Innoviva (INVA) has disclosed EPS (Weighted Average and Diluted) for 15 consecutive years, with $1.35 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 6650.0% year-over-year to $1.35, compared with a TTM value of $1.61 through Sep 2025, up 16.67%, and an annual FY2025 reading of $3.3, up 816.67% over the prior year.
  • EPS (Weighted Average and Diluted) was $1.35 for Q3 2025 at Innoviva, up from $0.98 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $2.8 in Q3 2022 and bottomed at -$0.74 in Q1 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.61, with a median of $0.46 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) crashed 2850.0% in 2024, then surged 6650.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.9 in 2021, then surged by 211.11% to $2.8 in 2022, then tumbled by 48.21% to $1.45 in 2023, then crashed by 98.62% to $0.02 in 2024, then soared by 6650.0% to $1.35 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for INVA at $1.35 in Q3 2025, $0.98 in Q2 2025, and -$0.74 in Q1 2025.